Subscribe
shutterstock_1528056221_jhvephoto
JHVEphoto / Shutterstock.com
25 May 2023MedtechLiz Hockley

Split Fed Cir refutes Medtronic challenge to catheter patents

Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Biotechnology
Teleflex inks $650m deal with Nordic pharma firm
27 July 2023   Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.
Big Pharma
Fed Circ sides with Axonics in patent validity battle
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Big Pharma
Fed Circ sides with Axonics in patent validity battle
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
Teleflex inks $650m deal with Nordic pharma firm
27 July 2023   Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.

More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Big Pharma
Fed Circ sides with Axonics in patent validity battle
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.
Biotechnology
Teleflex inks $650m deal with Nordic pharma firm
27 July 2023   Swedish company’s products treat urologic disorders and colorectal conditions | Portfolio includes unique treatment for prostate cancer radiation therapy.

More features

UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Bristol Myers Squibb leader named INTA 2025 president
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks